vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and NEW YORK TIMES CO (NYT). Click either name above to swap in a different company.

NEW YORK TIMES CO is the larger business by last-quarter revenue ($802.3M vs $510.9M, roughly 1.6× Genius Sports Ltd). NEW YORK TIMES CO runs the higher net margin — 16.2% vs -12.3%, a 28.5% gap on every dollar of revenue. NEW YORK TIMES CO produced more free cash flow last quarter ($157.6M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 16.2%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

The New York Times Company is an American mass media corporation that publishes The New York Times and its associated publications such as The New York Times International Edition and other media properties. The New York Times Company's headquarters are in the New York Times Building, a skyscraper in Manhattan, New York City.

GENI vs NYT — Head-to-Head

Bigger by revenue
NYT
NYT
1.6× larger
NYT
$802.3M
$510.9M
GENI
Higher net margin
NYT
NYT
28.5% more per $
NYT
16.2%
-12.3%
GENI
More free cash flow
NYT
NYT
$88.1M more FCF
NYT
$157.6M
$69.6M
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
16.2%
NYT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENI
GENI
NYT
NYT
Revenue
$510.9M
$802.3M
Net Profit
$-63.0M
$129.8M
Gross Margin
25.2%
Operating Margin
-11.5%
20.1%
Net Margin
-12.3%
16.2%
Revenue YoY
10.4%
Net Profit YoY
4.9%
EPS (diluted)
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
NYT
NYT
Q4 25
$510.9M
$802.3M
Q3 25
$335.4M
$700.8M
Q2 25
$215.2M
$685.9M
Q1 25
$119.7M
$635.9M
Q4 24
$413.0M
$726.6M
Q3 24
$285.8M
$640.2M
Q2 24
$184.1M
$625.1M
Q1 24
$97.2M
$594.0M
Net Profit
GENI
GENI
NYT
NYT
Q4 25
$-63.0M
$129.8M
Q3 25
$81.6M
Q2 25
$-47.3M
$82.9M
Q1 25
$-25.5M
$49.6M
Q4 24
$-85.5M
$123.7M
Q3 24
$-47.1M
$64.1M
Q2 24
$-35.5M
$65.5M
Q1 24
$-25.2M
$40.4M
Gross Margin
GENI
GENI
NYT
NYT
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Q1 24
9.8%
Operating Margin
GENI
GENI
NYT
NYT
Q4 25
-11.5%
20.1%
Q3 25
-15.3%
15.0%
Q2 25
-21.0%
15.5%
Q1 25
-20.3%
9.2%
Q4 24
-18.0%
20.2%
Q3 24
-13.9%
12.0%
Q2 24
-16.8%
12.7%
Q1 24
-23.7%
8.1%
Net Margin
GENI
GENI
NYT
NYT
Q4 25
-12.3%
16.2%
Q3 25
11.7%
Q2 25
-22.0%
12.1%
Q1 25
-21.3%
7.8%
Q4 24
-20.7%
17.0%
Q3 24
-16.5%
10.0%
Q2 24
-19.3%
10.5%
Q1 24
-25.9%
6.8%
EPS (diluted)
GENI
GENI
NYT
NYT
Q4 25
$0.79
Q3 25
$0.50
Q2 25
$0.50
Q1 25
$0.30
Q4 24
$0.74
Q3 24
$0.39
Q2 24
$0.40
Q1 24
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
NYT
NYT
Cash + ST InvestmentsLiquidity on hand
$280.6M
$642.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$724.5M
$2.0B
Total Assets
$1.1B
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
NYT
NYT
Q4 25
$280.6M
$642.2M
Q3 25
$110.2M
$617.4M
Q2 25
$110.2M
$540.2M
Q1 25
$110.2M
$522.1M
Q4 24
$100.3M
$565.9M
Q3 24
$100.3M
$492.9M
Q2 24
$100.3M
$411.4M
Q1 24
$100.3M
$379.1M
Stockholders' Equity
GENI
GENI
NYT
NYT
Q4 25
$724.5M
$2.0B
Q3 25
$572.4M
$2.0B
Q2 25
$572.4M
$1.9B
Q1 25
$572.4M
$1.9B
Q4 24
$573.0M
$1.9B
Q3 24
$573.0M
$1.9B
Q2 24
$573.0M
$1.8B
Q1 24
$573.0M
$1.7B
Total Assets
GENI
GENI
NYT
NYT
Q4 25
$1.1B
$3.0B
Q3 25
$792.3M
$2.9B
Q2 25
$792.3M
$2.8B
Q1 25
$792.3M
$2.7B
Q4 24
$775.7M
$2.8B
Q3 24
$775.7M
$2.8B
Q2 24
$775.7M
$2.7B
Q1 24
$775.7M
$2.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
NYT
NYT
Operating Cash FlowLast quarter
$81.9M
$164.2M
Free Cash FlowOCF − Capex
$69.6M
$157.6M
FCF MarginFCF / Revenue
13.6%
19.6%
Capex IntensityCapex / Revenue
2.4%
0.8%
Cash ConversionOCF / Net Profit
1.26×
TTM Free Cash FlowTrailing 4 quarters
$33.5M
$550.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
NYT
NYT
Q4 25
$81.9M
$164.2M
Q3 25
$-4.8M
$207.6M
Q2 25
$-1.2M
$113.6M
Q1 25
$-14.6M
$99.1M
Q4 24
$14.9M
$151.7M
Q3 24
$-9.2M
$125.5M
Q2 24
$80.2M
Q1 24
$53.1M
Free Cash Flow
GENI
GENI
NYT
NYT
Q4 25
$69.6M
$157.6M
Q3 25
$-14.2M
$199.7M
Q2 25
$-5.8M
$103.3M
Q1 25
$-16.0M
$89.9M
Q4 24
$11.3M
$143.6M
Q3 24
$-11.6M
$118.4M
Q2 24
$72.6M
Q1 24
$46.7M
FCF Margin
GENI
GENI
NYT
NYT
Q4 25
13.6%
19.6%
Q3 25
-4.2%
28.5%
Q2 25
-2.7%
15.1%
Q1 25
-13.4%
14.1%
Q4 24
2.7%
19.8%
Q3 24
-4.1%
18.5%
Q2 24
11.6%
Q1 24
7.9%
Capex Intensity
GENI
GENI
NYT
NYT
Q4 25
2.4%
0.8%
Q3 25
2.8%
1.1%
Q2 25
2.1%
1.5%
Q1 25
1.2%
1.5%
Q4 24
0.9%
1.1%
Q3 24
0.9%
1.1%
Q2 24
1.2%
Q1 24
1.1%
Cash Conversion
GENI
GENI
NYT
NYT
Q4 25
1.26×
Q3 25
2.54×
Q2 25
1.37×
Q1 25
2.00×
Q4 24
1.23×
Q3 24
1.96×
Q2 24
1.22×
Q1 24
1.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENI
GENI

Segment breakdown not available.

NYT
NYT

Subscription$510.5M64%
Advertising$191.7M24%
Affiliate Licensing And Other Products And Services$100.2M12%

Related Comparisons